|
|
Volumn 17, Issue 5, 2011, Pages 523-
|
|
Companies race to develop first Hedgehog inhibitor cancer drug
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPAMINE;
SONIC HEDGEHOG PROTEIN;
VERATRUM ALKALOID;
BASAL CELL CARCINOMA;
DRUG ANTAGONISM;
DRUG DEVELOPMENT;
DRUG EFFECT;
DRUG INDUSTRY;
HUMAN;
NOTE;
SIGNAL TRANSDUCTION;
SKIN TUMOR;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, BASAL CELL;
DRUG DISCOVERY;
DRUG INDUSTRY;
HEDGEHOG PROTEINS;
HUMANS;
SIGNAL TRANSDUCTION;
SKIN NEOPLASMS;
VERATRUM ALKALOIDS;
|
|
EID: 79960061444
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0511-523 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|